| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.8 |